Check-Cap (MBAI) Non-Current Deferred Tax Liability (2025)
Check-Cap (MBAI) posted Non-Current Deferred Tax Liability of $43626.0 for Q4 2025.
Check-Cap (MBAI) Non-Current Deferred Tax Liability (2025) Analysis & Trends
Check-Cap has reported Non-Current Deferred Tax Liability for 1 years, with the latest figure at $43626.0 in Q4 2025.
- Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $43626.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $43626.0 (changed N/A YoY) and the FY2025 annual result came in at $43626.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability steadied at $43626.0 in Q4 2025 per MBAI's latest filing.
- Over five years, Non-Current Deferred Tax Liability peaked at $43626.0 in Q4 2025 and troughed at $43626.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Check-Cap | 8.23 Mn | 6.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43,626.00 |
| Dec 31, 2025 | 43,626.00 |